Format

Send to

Choose Destination
Nat Commun. 2014 Mar 17;5:3479. doi: 10.1038/ncomms4479.

Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production.

Author information

1
Department of Pharmacology and Cancer Biology, DUMC, Box 3813, Durham, North Carolina 27710, USA.
2
Department of Immunology, DUMC, Box 3010, Durham, North Carolina 27710, USA.
3
Department of Chemistry, Duke University, 124 Science Drive, Durham, North Carolina 27710, USA.

Abstract

Reversible acetylation of α-tubulin is an evolutionarily conserved modification in microtubule networks. Despite its prevalence, the physiological function and regulation of microtubule acetylation remain poorly understood. Here we report that macrophages challenged by bacterial lipopolysaccharides (LPS) undergo extensive microtubule acetylation. Suppression of LPS-induced microtubule acetylation by inactivating the tubulin acetyltransferase, MEC17, profoundly inhibits the induction of anti-inflammatory interleukin-10 (IL-10), a phenotype effectively reversed by an acetylation-mimicking α-tubulin mutant. Conversely, elevating microtubule acetylation by inhibiting the tubulin deacetylase, HDAC6, or stabilizing microtubules via Taxol stimulates IL-10 hyper-induction. Supporting the anti-inflammatory function of microtubule acetylation, HDAC6 inhibition significantly protects mice from LPS toxicity. In HDAC6-deficient macrophages challenged by LPS, p38 kinase signalling becomes selectively amplified, leading to SP1-dependent IL-10 transcription. Remarkably, the augmented p38 signalling is suppressed by MEC17 inactivation. Our findings identify reversible microtubule acetylation as a kinase signalling modulator and a key component in the inflammatory response.

PMID:
24632940
PMCID:
PMC4000527
DOI:
10.1038/ncomms4479
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center